Clinical Trial Update: Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating depigmented and polymerized Phleum pratense allergen extract for allergic rhinitis, allergic conjunctivitis, and asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis
• Asthma

Drugs mentioned

• Depigmented and polymerized Phleum pratense allergen extract (depigmented and polymerized Phleum pratense allergen extract)

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic | Phase 2 | Status: COMPLETED